高级检索
当前位置: 首页 > 详情页

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 自然指数

机构: [1]State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangzhou, China. [2]Nanfang Hospital, Southern Medical University, Guangzhou, China. [3]Kingmed Center for Clinical Laboratory, Guangzhou, China. [4]The First People's Hospital of Foshan, Foshan, China. [5]The People's Hospital of Honghu, Honghu, China. [6]The First People's Hospital of Jingzhou, Jingzhou, China. [7]Jingzhou Central Hospital, Jingzhou, China. [8]Honghu Traditional Chinese Medicine Hospital, Honghu, China. [9]The Second People's Hospital of Honghu, Honghu, China. [10]Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hung Hom, Hong Kong, China. [11]Department of Computer Science and Technology, Tsinghua University, Beijing, China. [12]The Sichuan Provincial Key Laboratory of Human Disease Study, Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. [13]Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. ahuang1964@163.com. [14]The Sichuan Provincial Key Laboratory of Human Disease Study, Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. zliny@yahoo.com. [15]Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macau, China. kang.zhang@gmail.com. [16]Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China. kang.zhang@gmail.com. [17]State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangzhou, China. ffhouguangzhou@163.com. [18]Nanfang Hospital, Southern Medical University, Guangzhou, China. ffhouguangzhou@163.com. [19]Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China. ffhouguangzhou@163.com.
出处:
ISSN:

摘要:
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 细胞生物学 1 区 医学:研究与实验
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 细胞生物学 1 区 医学:研究与实验
JCR分区:
出版当年[2018]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL Q1 CELL BIOLOGY Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangzhou, China. [2]Nanfang Hospital, Southern Medical University, Guangzhou, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2021 今日访问量:0 总访问量:646 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号